A bill to reform the Toxic Substances Control Act is likely to be introduced in Congress next week. Given some chemicals’ effects on causing early puberty in girls, reproductive health advocates should demand strong regulation that removes harmful chemical substances from the market.
San Francisco Supervisors David Weiner and Scott Campos last week held a hearing to discuss the efforts of a coalition formed to end HIV in a city that was once seen as a center of the epidemic in this country.
Citing inaccurate science, a leading Colorado lawmaker is signaling he’ll oppose providing funds for a state program that, during a five-year privately-supported test phase, reduced teen pregnancies by 40 percent.
This week, the FDA warns of real Viagra in supposedly all natural supplements, a survey finds less than half of adults polled in Japan had sex in the last month, and we theorize about what method of contraception was available to the ladies of Downton Abbey.
The agenda is “a powerful platform for us to really organize ourselves, to speak on our own behalf, and to be at the table when decisions are being made about us,” said La’Tasha Mayes, founder and executive director at New Voices Pittsburgh.
Virginia lawmakers on Wednesday filed a handful of bills related to reproductive and sexual health—and they are almost all pro-choice, and could roll back anti-choice policies pushed through by Virginia Republicans in recent years.
Because Depo-Provera is an important contraceptive choice and because in many parts of the world, it is the only long-acting, discreet option available to women, it is vital to take the issue of a link between HIV and hormonal contraception quite seriously while adding nuance to the discussion.
As data emerges showing that syphilis rates are up yet again, the FDA has granted a waiver allowing a rapid test for the infection to be conducted in doctor’s offices, clinics, emergency rooms, maternity wards, and other non-laboratory settings. Experts hope that access to immediate results can increase both treatment and prevention and stem the tides of this growing epidemic.
Gardasil 9, the newest version of the HPV vaccine to be approved by the FDA, has the potential to prevent 90 percent of cases of cervical, vulvar, vaginal, and anal cancers, but only if the vaccine becomes more widely accepted.
While physically taking X-Acto knives to textbooks is extreme and rare, the struggle to mandate what these texts do and do not teach children is not rare in the slightest—and it can manifest in ways that are far more insidious than ripping pages out of a book.